Synthekine Announces Strategic Collaboration with Sanofi to Develop Selective IL-10 Agonists for Treatment of Inflammatory Diseases
Synthekine Inc., an engineered cytokine therapeutics company, today announced a worldwide collaboration with Sanofi (EURONEXT: SAN and NASDAQ: SNY) to develop and commercialize IL-10 receptor agonists for the